top of page
Businessmen

Forging a Future

Innovative

OUR HISTORY

Origins of Transformative Success

It was born as a Colombian initiative by a group of entrepreneurs with multinational experience in the development, marketing and sale of products in the health sector. It began as a Business Unit that was very quickly formalized in 2012 with the Acquisition of the Exclusive Rights of  Distribution in the Colombian Market of Botulinum Toxin Type A, international brand BTXA, Chinese product with more than 20 years of experience in Asia and Latin American countries

 

Leveraged on the success of this project, we sold it to North American investors and with the existing “pipeline” we developed a new entrepreneurial task for the Antiaging Market “Antiaging Market” with an Exclusive Distribution contract for Colombia from a Korean company of recognized global prestige. Given the success of this last Company  before  of its maturation it was sold

ABOUT US

Global Experience to Drive Growth

We are a company focused on the Pharmaceutical area with Global coverage that acts as  a Consultant Specialized in the search for opportunities to expand businesses in the health sector.

 

It is made up of several Professionals with more than 30 years in the sector with experience in Multinational Pharmaceutical companies and with a Network of solid contacts not only in Latin America but also worldwide. interested in expanding via licensing, distribution or product manufacturing.

WHAT DO WE DO

Driving Innovation and Strategic Growth

We are dedicated to the study of the sector to identify the strategic expansion of businesses in the Global market, increasing the competitiveness of organizations through constant improvement of their portfolio via concentration or expansion of their offer.

 

We accompany our clients in the study, evaluation and financial valuation of their businesses  current and future. And we assist them to provide the talent  human necessary to achieve its goals.

 

Acquiring new products or business units or companies that allow them to advance to new biotechnology developments  or therapeutic; acquiring cutting-edge technology with new competitive advantages in its value proposition.

 

We close our advice by accompanying the client with financing alternatives and  network of contacts at a global level in essential technical aspects in the segment where we operate.

bottom of page